| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters
|
Bullifent, Helen L.
|
|
2000
|
18 |
24 |
p. 2668-2676
9 p.
|
article
|
| 2 |
A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin
|
Dokmetjian, J.
|
|
2000
|
18 |
24 |
p. 2698-2703
6 p.
|
article
|
| 3 |
Development of a multi-specificity opsonophagocytic killing assay
|
Nahm, Moon H
|
|
2000
|
18 |
24 |
p. 2768-2771
4 p.
|
article
|
| 4 |
Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H
|
Tebbey, Paul W
|
|
2000
|
18 |
24 |
p. 2723-2734
12 p.
|
article
|
| 5 |
Further development of the Helicobacter pylori mouse vaccination model
|
Sutton, Philip
|
|
2000
|
18 |
24 |
p. 2677-2685
9 p.
|
article
|
| 6 |
Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: MalE
|
Himmelrich, Hayo
|
|
2000
|
18 |
24 |
p. 2636-2647
12 p.
|
article
|
| 7 |
Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial
|
Choo, Sharon
|
|
2000
|
18 |
24 |
p. 2686-2692
7 p.
|
article
|
| 8 |
Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide
|
Humphreys, R.E.
|
|
2000
|
18 |
24 |
p. 2693-2697
5 p.
|
article
|
| 9 |
Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)
|
Matsuo, Kazutoshi
|
|
2000
|
18 |
24 |
p. 2713-2722
10 p.
|
article
|
| 10 |
Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate
|
Goetsch, Liliane
|
|
2000
|
18 |
24 |
p. 2735-2742
8 p.
|
article
|
| 11 |
Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na
|
Goestch, Liliane
|
|
2000
|
18 |
24 |
p. 2648-2655
8 p.
|
article
|
| 12 |
Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides
|
Cano, François
|
|
2000
|
18 |
24 |
p. 2743-2752
10 p.
|
article
|
| 13 |
Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy
|
Strady, C
|
|
2000
|
18 |
24 |
p. 2661-2667
7 p.
|
article
|
| 14 |
Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children
|
Qadri, Firdausi
|
|
2000
|
18 |
24 |
p. 2704-2712
9 p.
|
article
|
| 15 |
Seroconversion and duration of immunity after vaccination against group C meningococcal infection in young children
|
Espı́n Rı́os, Isabel
|
|
2000
|
18 |
24 |
p. 2656-2660
5 p.
|
article
|
| 16 |
The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity
|
Enioutina, Elena Y
|
|
2000
|
18 |
24 |
p. 2753-2767
15 p.
|
article
|
| 17 |
The introduction of new vaccines into developing countries II. Vaccine financing
|
Mahoney, Richard T
|
|
2000
|
18 |
24 |
p. 2625-2635
11 p.
|
article
|
Journal description